Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)

Blood Cancer Journal, Published online: 27 August 2019; doi:10.1038/s41408-019-0228-2Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)

http://feeds.nature.com/~r/bcj/rss/current/~3/RDRLk0vb6os/s41408-019-0228-2

Source: Blood Cancer Journal - August 26, 2019 Category: Hematology Authors: F. Hitz M. Kraus T. Pabst D. Hess L. Besse T. Silzle U. Novak K. Seipel S. Rondeau S. St üdeli S. Berardi Vilei P. Samaras U. Mey C. Driessen Source Type: research